Starting a new business venture is an exciting time in…
Bard Ivc Filter Lawsuit Funding[flexy_breadcrumb]
The Bard IVC filter, also referred to as the Bard G2 IVC filter and the Bard Recovery filter, is a small medical device implanted in the vein that carries blood to the heart, which is called the inferior vena cava. This medical device operates by catching blood clots before they can travel to the lungs and possibly cause a pulmonary embolism. Recently, the IVC filter has been linked to high rates of failure and severe medical complications that can be fatal. If you or a loved one has been a victim of complications from a Bard IVC filter, please contact our experienced attorneys as soon as possible. You may be entitled to compensation for your pain and emotional distress.
An IVC filter is a small wire device that is implanted in the inferior vena cava. The object is used to prevent blood clots that may result in a pulmonary embolism. Patients who have a high risk for pulmonary embolisms often get temporary or permanent IVC filters. The inferior vena cava is the vein that carries blood from the the lower half of the body to the right side of the heart. This vein gives oxygen to the lungs by pumping blood. Blood clots in the lower body are the leading cause of pulmonary embolisms, which occur when blood clots become trapped in the small vessels located in the lungs. Many times, these blood clots can be fatal and often cause irreversible tissue damage. About 30 percent of individuals with an untreated pulmonary embolism die.
Serious side effects associated with the Bard IVC filter include perforation of the inferior vena cava, heart or lungs, filter fractures, filter migration, chest pain, excess fluid near organs and deep vein thrombosis. There are many other potential problems associated with the medical device. For example, the object may move or become stuck in a place where it’s not supposed to be. Moreover, this could cause the device to no longer be effective and even damage internal organs. Additionally, the filter can perforate or erode the inferior vena cava. Furthermore, parts of the device could break off and travel into the bloodstream and damage vital organs such as the heart or lungs. The filter could also become clogged with clots and block blood flow to the heart. Finally, if the device breaks in the body, a doctor may be unable to remove all of the pieces.
The Archives of Internal Medicine published a study that revealed a high rate of fractures and fragment embolizations in individuals who had received the Bard IVC filter. This study, by Dr. William Nicholson, was done after one of the doctor’s patients suffered chest pain and fluid build-up around their heart. Their right ventricle had also been perforated from the device. The doctor asked his 80 patients who had received the device to be examined. Dr. Nicholson found that the device had fractured and caused embolisms in 25 percent of his patients who had received the older Bard IVC filter. Additionally, one of the patients had died suddenly. 12 percent of those who had received the Bard G2 IVC had fractured devices, and two of those patients had embolization caused by debris from the filter. While the newer device had a smaller rate of failure, complications may increase over time.
Another study published in the American Journal of Medicine found that IVC filters don’t significantly reduce the mortality rate in stable patients who had a high risk of pulmonary embolisms. While the device was effective in unstable patients, this group was minor. The study raised concerns about the benefits of using IVC filters when taking into consideration the large number of complications the device can cause. The lead researcher, Dr. Paul Stein, found that the use of filters don’t significantly reduce mortality, and only a small portion of individuals should even consider receiving the device.
Furthermore, a study published in the Journal of the American College of Cardiology on May 2, 2014, found that while IVC filters reduce the risk of pulmonary embolisms, they increased the risk of VTE. The study was conducted on a group of 344 patients who received an IVC filter and a control group of 344 patients who did not receive the device. The first group was examined for 30 days after implantation. Both groups had the same risk of death; however, the group that had received the IVC filter had a significant risk of VTE. VTE or venous thromboembolism is a serious medical condition that can be fatal. It’s when a blood clot grows within a deep vein. When this blood clot breaks loose, it can travel through the bloodstream and get trapped in the lungs and heart causing a pulmonary embolism.
On August 9, 2010, the FDA issued a safety warning regarding the Bard IVC filter. Originally, the device was designed as a temporary, retrievable object. The FDA’s main concern was that the device was not being removed once a patient’s risk of pulmonary embolism had subsided. The safety warning was prompted by 921 reports of adverse effects related to the Bard IVC filter. From these reports, 328 patients had suffered from device migration. Additionally, 146 of those involved had IVC filters that were broken with pieces in their bloodstream. 70 individuals from the group suffered perforations in their inferior vena cava. Finally, 56 patients had filter fractures. These complications may have been caused by the device being left inside a patient for an excessive amount of time.
As of January 2013, there were three class action lawsuits against C.R. Bard for patient medical complications involving the company’s IVC filter product. These cases were opened in California, Pennsylvania and Florida. If you received the IVC filter, regardless of the state you reside in, you may be entitled to financial compensation from a lawsuit. Two patients in Illinois have filed lawsuits regarding the Bard IVC filter devices. One patient’s filter had shattered into pieces, and this debris had traveled to her heart and lungs. She was required to have emergency surgery and have the pieces removed. Parts of the filter still remain in her lungs. The other patient had needed open-heart surgery due to complications from the device.
If you have an on-going lawsuit, and need a cash advance against the future value of your claim – we encourage you to contact us. We don’t charge a fee unless you win your case, which makes it easy and safe for you.